Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Renal Failure

Free Subscription Articles published in Am J Nephrol Retrieve available abstracts of 68 articles: HTML format

Single Articles

September 2025
1. ZHAO S, Zhong G, Lv A, Tao Y, et al
   Intradialytic Exercise Interventions to Enhance Physical Activity Levels in Hemodialysis Patients: A Systematic Review and Meta-analysis.
   Am J Nephrol. 2025 Sep 26:1-35. doi: 10.1159/000548114.
   PubMed     Abstract available
   
   
   
2. JIN H, Lu R, Cao J, Li H, et al
   Inflammation-Driven Differential Response to Intravenous versus Oral Iron Supplementation in Hemodialysis Patients: A Post Hoc Analysis of the IHOPE Trial.
   Am J Nephrol. 2025 Sep 8:1-21. doi: 10.1159/000548166.
   PubMed     Abstract available
   
   
   August 2025
3. MCDONNELL T, Soderberg M, Taal MW, Vuilleumier N, et al
   Plasma and Urinary KIM-1 in Chronic Kidney Disease: Prognostic Value, Associations with Albuminuria, and Implications for Kidney Failure and Mortality.
   Am J Nephrol. 2025 Aug 11:1-20. doi: 10.1159/000547867.
   PubMed     Abstract available
   
   
   
4. FALLAHTAFTI P, Semirani-Nezhad D, Maleki S, Zafarmandi S, et al
   Intensive vs. Less Intensive Blood Pressure Control in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Clinical Trials.
   Am J Nephrol. 2025 Aug 6:1-18. doi: 10.1159/000547812.
   PubMed     Abstract available
   
   
   
5. ZOMORODIAN A, Sakhaee K
   Vitamin D in Chronic Kidney Disease: Familiar Treatment, Unresolved Questions.
   Am J Nephrol. 2025 Aug 4:1-5. doi: 10.1159/000547690.
   PubMed    
   
   
   July 2025
6. KHAN LA, Alam B, Ladhwani NK, Abid H, et al
   Efficacy and safety of tenapanor in hemodialysis patients with hyperphosphatemia: a systematic review and meta-analysis of short term randomized control trails.
   Am J Nephrol. 2025 Jul 9:1-20. doi: 10.1159/000546265.
   PubMed     Abstract available
   
   
   June 2025
7. VASAN SK, Chinnadurai R, Rengarajan S, Green D, et al
   Utility of cardiac biomarkers (NT-proBNP and Hs-Troponin-T) in predicting mortality, cardiovascular and renal outcomes in patients with chronic kidney disease.
   Am J Nephrol. 2025 Jun 24:1-21. doi: 10.1159/000546489.
   PubMed     Abstract available
   
   
   
8. ALGHWIRI AA, Weltman MR, Lavenburg LU, Han Z, et al
   Using Machine learning to predict medication therapy problems among patients with chronic kidney disease.
   Am J Nephrol. 2025 Jun 17:1-16. doi: 10.1159/000546540.
   PubMed     Abstract available
   
   
   
9. BISHOP CW, Ashfaq A, Choe J, Strugnell SA, et al
   Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Randomized Clinical Trial.
   Am J Nephrol. 2025 Jun 4:1-19. doi: 10.1159/000546615.
   PubMed     Abstract available
   
   
   May 2025
10. YOON SY, Jeong SJ, Kim JS, Hwang HS, et al
    Time in target range of systolic blood pressure and cardiovascular disease in patients with chronic kidney disease: A Korean nationwide cohort study.
    Am J Nephrol. 2025 May 19:1-21. doi: 10.1159/000546380.
    PubMed     Abstract available
    
    
    
11. GHILDAYAL N, Liu Y, Hong J, Li Y, et al
    Intradialytic Cognitive and Aerobic Exercise Training to Preserve Cognitive Function: IMPCT, A Multi-Dialysis Center 2x2 Factorial Block-Randomized Controlled Trial.
    Am J Nephrol. 2025 May 10:1-23. doi: 10.1159/000546296.
    PubMed     Abstract available
    
    
    
12. WANG L, Cao Y, Yuan W, Hao C, et al
    Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-dependent CKD Patients.
    Am J Nephrol. 2025 May 6:1-25. doi: 10.1159/000546158.
    PubMed     Abstract available
    
    
    
13. KHAIRALLAH P, Liu S, Montez-Rath ME, Erickson KF, et al
    Association Between Parathyroid Hormone Concentration and Incident Atrial Fibrillation in Older Persons with Kidney Failure Initiating Dialysis.
    Am J Nephrol. 2025 May 5:1-18. doi: 10.1159/000546266.
    PubMed     Abstract available
    
    
    April 2025
14. LEE CC, Chao JY, Liu KH, Lin WR, et al
    Longitudinal Changes in Peritoneal Transport and Their Impact on Dialysis Outcomes: A Machine Learning Approach integrating Clinical and Biomarker Data.
    Am J Nephrol. 2025 Apr 18:1-25. doi: 10.1159/000545943.
    PubMed     Abstract available
    
    
    March 2025
15. SONG S, Cai X, Shen D, Hu J, et al
    Relationship between cumulative exposure and time course of plasma aldosterone concentrations and chronic kidney disease in hypertensive patients: a real-world cohort study.
    Am J Nephrol. 2025 Mar 29:1-22. doi: 10.1159/000545451.
    PubMed     Abstract available
    
    
    
16. LI D, Xie D, Gu A, Yang Y, et al
    Pharmacokinetic Properties of Dapagliflozin in Patients with Stage 4 Chronic Kidney Disease.
    Am J Nephrol. 2025 Mar 14:1-16. doi: 10.1159/000544936.
    PubMed     Abstract available
    
    
    
17. OKAMURA K, Tanaka S, Kitamura H, Suenaga T, et al
    Associations Between Multimorbidity and the Risks of Cardiovascular Disease Events and All-Cause Mortality in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2025 Mar 13:1-25. doi: 10.1159/000544722.
    PubMed     Abstract available
    
    
    
18. CHANDER S, Latif R, Bin Aamir A, Sorath F, et al
    Clinical outcomes of patients undergoing hemodialysis with cool versus standard dialysate: A systematic review and meta-analysis.
    Am J Nephrol. 2025 Mar 3:1-28. doi: 10.1159/000544924.
    PubMed     Abstract available
    
    
    February 2025
19. LIM W, Gately R, Teixeira-Pinto A, Lopez P, et al
    Sex disparity and the uptake of home dialysis following kidney transplant failure.
    Am J Nephrol. 2025 Feb 26:1-19. doi: 10.1159/000543788.
    PubMed     Abstract available
    
    
    
20. WESTERMANN L, Nolde JM, Wiegel J, Buchler G, et al
    Impact of Renin-Angiotensin-Aldosterone System Inhibition on Advanced Chronic Kidney Disease Progression - a Retrospective Observational Study.
    Am J Nephrol. 2025 Feb 26:1-15. doi: 10.1159/000543487.
    PubMed     Abstract available
    
    
    
21. JI J, Lu M, Guo S, Xiang B, et al
    Five-year Time Profiles of Clearances of Different Uremic Solutes in Incident Peritoneal Dialysis Patients.
    Am J Nephrol. 2025 Feb 25:1-17. doi: 10.1159/000543622.
    PubMed     Abstract available
    
    
    
22. ASHFAQ A, Choe J, Strugnell SA, Patel N, et al
    Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (ERC) in non-dialysis chronic kidney disease (ND-CKD).
    Am J Nephrol. 2025 Feb 21:1-21. doi: 10.1159/000544086.
    PubMed     Abstract available
    
    
    
23. HAMANO N, Komaba H, Tanaka H, Takahashi H, et al
    Fibroblast Growth Factor 23, Endogenous Erythropoietin, Erythropoiesis-Stimulating Agents, and Erythropoietin Resistance in Hemodialysis Patients.
    Am J Nephrol. 2025 Feb 20:1-9. doi: 10.1159/000543506.
    PubMed     Abstract available
    
    
    
24. YAO C, Wei W, Wu G, Zhang Y, et al
    DOT1L regulates cellular senescence during the progression from acute kidney injury to chronic kidney disease via the micro-222-5p/WNT9B signaling pathway.
    Am J Nephrol. 2025 Feb 12:1-20. doi: 10.1159/000544694.
    PubMed     Abstract available
    
    
    
25. POULAIN L, Bechade C, Lanot A, Ficheux M, et al
    Early-onset peritonitis and outcomes of peritoneal dialysis: A cohort study with data from the RDPLF.
    Am J Nephrol. 2025 Feb 3:1-23. doi: 10.1159/000542835.
    PubMed     Abstract available
    
    
    January 2025
26. NISHIWAKI H, Imaizumi T, Hasegawa T, Kosugi T, et al
    Association between serum iron store biomarkers and all-cause mortality in Japanese patients undergoing hemodialysis: a nationwide cohort study.
    Am J Nephrol. 2025 Jan 31:1-23. doi: 10.1159/000543888.
    PubMed     Abstract available
    
    
    
27. HORI M, Takahashi H, Kondo C, Takeda A, et al
    Association between serum zinc levels and trabecular bone scores among patients undergoing chronic hemodialysis.
    Am J Nephrol. 2025 Jan 24:1-13. doi: 10.1159/000543756.
    PubMed     Abstract available
    
    
    
28. LIN YT, Tsai MT, Chen TW, Lin CC, et al
    Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis.
    Am J Nephrol. 2025 Jan 22:1-19. doi: 10.1159/000543598.
    PubMed     Abstract available
    
    
    
29. PHONGPHITHAKCHAI A, Bellomo R, Mount P, Bach CT, et al
    A pilot, single-blinded, randomized cross-over trial of cramp reduction with angiotensin II in maintenance patients on hemodialysis (The CRAMP-HD study).
    Am J Nephrol. 2025 Jan 14:1-19. doi: 10.1159/000543280.
    PubMed     Abstract available
    
    
    
30. KITAMURA H, Tanaka S, Hiyamuta H, Tsuruya K, et al
    Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney disease Registry (FKR) Study.
    Am J Nephrol. 2025 Jan 8:1-21. doi: 10.1159/000543201.
    PubMed     Abstract available
    
    
    
31. YU H, Kim SJ, Bae Y, Kim M, et al
    Sex differences in the risk of bladder cancer among kidney transplant recipients and patients with kidney failure receiving hemodialysis: a nationwide cohort study.
    Am J Nephrol. 2025 Jan 7:1-16. doi: 10.1159/000543298.
    PubMed     Abstract available
    
    
    
32. KOH J, Yang J, Lee KB, Kim J, et al
    Performance of new race-free eGFR equations for predicting complications in chronic kidney disease: From the KNOW-CKD study.
    Am J Nephrol. 2025 Jan 2:1-17. doi: 10.1159/000543324.
    PubMed     Abstract available
    
    
    
33. CHADE AR, Tharp DL, Sitz R, McCarthy EA, et al
    A NEW MODEL OF CHRONIC KIDNEY DISEASE, METABOLIC DERANGEMENTS, AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN AGING SWINE.
    Am J Nephrol. 2025 Jan 2:1-20. doi: 10.1159/000543327.
    PubMed     Abstract available
    
    
    
34. FENG L, Song X, Shi X, Qin M, et al
    Off-Label Use of Mycophenolate Mofetil in Immunoglobulin A Nephropathy: A Systematic Review and Meta-Analysis.
    Am J Nephrol. 2025;56:35-47.
    PubMed     Abstract available
    
    
    
35. JEON J, Shin DW, Park SH, Jung JH, et al
    Kidney and Cardiovascular Outcomes in Older Population with Mildly to Moderately Decreased Kidney Function: A Nationwide Cohort Study.
    Am J Nephrol. 2025;56:123-135.
    PubMed     Abstract available
    
    
    
36. TAKAHASHI R, Bui TA, Elali I, Tran D, et al
    The Association of Niacin Use with Kidney Outcomes and Mortality.
    Am J Nephrol. 2025;56:457-467.
    PubMed     Abstract available
    
    
    
37. MCDONALD S, Stallard BC, McDonald SP
    Gender Differences in Kidney Failure Incidence in Australia: A Registry Study.
    Am J Nephrol. 2025;56:571-576.
    PubMed     Abstract available
    
    
    December 2024
38. LI W, Cao T, Huang G, Guo J, et al
    Effects of roxadustat on thyroid profiles in patients and animals with chronic kidney disease.
    Am J Nephrol. 2024 Dec 9:1-23. doi: 10.1159/000542699.
    PubMed     Abstract available
    
    
    November 2024
39. KIM I, Min SH, Lee HW, An JN, et al
    Impact of Peritoneal Neutrophil Extracellular Traps on Peritoneal Characteristics and Technical Failure in Patients Undergoing Peritoneal Dialysis.
    Am J Nephrol. 2024 Nov 7:1-17. doi: 10.1159/000542427.
    PubMed     Abstract available
    
    
    
40. FERREIRA JP, Oliveira AC, Vasques-Novoa F, Leite AR, et al
    Mineralocorticoid receptor antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor alone in chronic kidney disease: a meta-analysis of randomized trials.
    Am J Nephrol. 2024 Nov 7:1-13. doi: 10.1159/000541686.
    PubMed     Abstract available
    
    
    
41. ZOCCALI C, Mallamaci F
    The Interplay of Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Call for Integrated Management.
    Am J Nephrol. 2024 Nov 5:1-4. doi: 10.1159/000541889.
    PubMed    
    
    
    October 2024
42. SHIAO CC, Chiu CW, Chang YM, Liu MC, et al
    Comprehensive Evaluation of the Cardiovascular Protective Effects of SGLT2 Inhibitors in Patients with Advanced Chronic Kidney Disease: A Real-World Evidence.
    Am J Nephrol. 2024 Oct 21:1-28. doi: 10.1159/000542132.
    PubMed     Abstract available
    
    
    
43. CHUANG GT, Hsiung CN, Che TP, Chang YC, et al
    Discovering Novel Loci of Chronic Kidney Disease via Principal Component Analysis based Multiple-trait Genome?wide Association Study.
    Am J Nephrol. 2024 Oct 21:1-25. doi: 10.1159/000541982.
    PubMed     Abstract available
    
    
    
44. PARK CH, Lim H, Kim YN, Kim JY, et al
    Non-alcoholic Fatty Liver Disease (NAFLD) and its association with kidney and cardiovascular outcomes in moderate to advanced chronic kidney disease.
    Am J Nephrol. 2024 Oct 4:1-23. doi: 10.1159/000541803.
    PubMed     Abstract available
    
    
    September 2024
45. LUO W, Lei L, Lai J, Liu Y, et al
    A risk prediction model for new-onset chronic kidney disease in the elderly.
    Am J Nephrol. 2024 Sep 23:1-26. doi: 10.1159/000541510.
    PubMed     Abstract available
    
    
    
46. HAMANO T, Koiwa F, Isaka Y, Yokoyama K, et al
    Long-term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-label 52-week Study.
    Am J Nephrol. 2024 Sep 19:1-23. doi: 10.1159/000541493.
    PubMed     Abstract available
    
    
    
47. MURAKAMI M, Fujii N, Kanda E, Kikuchi K, et al
    Association between timing of vascular access creation and mortality in patients initiating hemodialysis: A nationwide cohort study in Japan.
    Am J Nephrol. 2024 Sep 7. doi: 10.1159/000541356.
    PubMed     Abstract available
    
    
    August 2024
48. VANEK L, Gulmez D, Kurnikowski A, Krenn S, et al
    Patient and caregiver perspectives on gender disparity in chronic kidney disease: Questionnaire survey, based on an interview study.
    Am J Nephrol. 2024 Aug 27. doi: 10.1159/000540850.
    PubMed     Abstract available
    
    
    
49. BISHOP CW, Ashfaq A, Strugnell SA, Choe J, et al
    Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients.
    Am J Nephrol. 2024 Aug 27. doi: 10.1159/000541138.
    PubMed     Abstract available
    
    
    
50. POLLOCK C, Carrero JJ, Kanda E, Ofori-Asenso R, et al
    The Lived Experience of Patients With Chronic Kidney Disease: Insights From DISCOVER CKD.
    Am J Nephrol. 2024 Aug 22. doi: 10.1159/000541064.
    PubMed     Abstract available
    
    
    
51. WEIR MR, Rossignol P, Pitt B, Lund LH, et al
    Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.
    Am J Nephrol. 2024 Aug 19. doi: 10.1159/000540453.
    PubMed     Abstract available
    
    
    
52. KIM IS, Lee HS, Jang J, An JN, et al
    Impact of Fat Mass on Osteoporosis, Sarcopenia, and Osteosarcopenia in Peritoneal Dialysis Patients.
    Am J Nephrol. 2024 Aug 17. doi: 10.1159/000540948.
    PubMed     Abstract available
    
    
    July 2024
53. BLOCK GA, Mizani MR, Broumand V, Newby FD, et al
    A Randomized Trial of the IMPACT of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.
    Am J Nephrol. 2024 Jul 5. doi: 10.1159/000540227.
    PubMed     Abstract available
    
    
    June 2024
54. ZIEGLER J, Morley K, Pilcher D, Bellomo R, et al
    Epidemiology of renal replacement therapy for critically ill patients across seven health jurisdictions.
    Am J Nephrol. 2024 Jun 18. doi: 10.1159/000539811.
    PubMed     Abstract available
    
    
    May 2024
55. SHAH AD, Vashisth S, Raker CA, Hu SL, et al
    Trends, Outcomes, and Economic Implications of Peritoneal Dialysis-Associated Peritonitis: A National Cohort Study.
    Am J Nephrol. 2024 May 30. doi: 10.1159/000539452.
    PubMed     Abstract available
    
    
    
56. MOLONEY BM, Chertow GM, Mc Causland FR
    Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
    Am J Nephrol. 2024 May 23. doi: 10.1159/000539451.
    PubMed     Abstract available
    
    
    
57. GARDEZI AI, Yuan Z, Aziz F, Parajuli S, et al
    Effect of End-Stage Renal Disease Prospective Payment System on Utilization of Peritoneal Dialysis in Patients with Kidney Allograft Failure.
    Am J Nephrol. 2024 May 16. doi: 10.1159/000539062.
    PubMed     Abstract available
    
    
    
58. VAN REETH O, Caliment A, de la Fuente Garcia I, Niel O, et al
    Safety profile and effectiveness of dapagliflozin in pediatric patients with chronic kidney disease.
    Am J Nephrol. 2024 May 11. doi: 10.1159/000539300.
    PubMed     Abstract available
    
    
    
59. GENDY N, Brown L, Staunton MK, Garg K, et al
    The Role of Angiopoietins in Cardiovascular Outcomes of Kidney Transplant Recipients- An Ancillary Study From the FAVORIT.
    Am J Nephrol. 2024 May 10. doi: 10.1159/000538878.
    PubMed     Abstract available
    
    
    April 2024
60. ALSULAMI MM, Al-Otaibi NE, Alshahrani WA, Altheaby A, et al
    The predictors and risk factors of two-year rejection in renal transplant patients: A multicenter case-control study.
    Am J Nephrol. 2024 Apr 26. doi: 10.1159/000538963.
    PubMed     Abstract available
    
    
    March 2024
61. LE D, Crews DC, Grams ME, Coresh J, et al
    Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis.
    Am J Nephrol. 2024 Mar 29. doi: 10.1159/000538253.
    PubMed     Abstract available
    
    
    
62. BOBOT M, Hak JF, Casolla B, Dehondt JD, et al
    Acute and chronic kidney dysfunction and prognosis following thrombectomy for ischemic stroke.
    Am J Nephrol. 2024 Mar 18. doi: 10.1159/000536493.
    PubMed     Abstract available
    
    
    
63. TSAI YL, Chung MH, Lin NC, Chen CY, et al
    The risk factors and clinical outcomes in hepatitis B seropositive and seronegative renal transplant patients.
    Am J Nephrol. 2024 Mar 18. doi: 10.1159/000538231.
    PubMed     Abstract available
    
    
    February 2024
64. STAVAS J, Silva AL, Wooldridge TD, Aqeel A, et al
    Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers.
    Am J Nephrol. 2024 Feb 29. doi: 10.1159/000537942.
    PubMed     Abstract available
    
    
    
65. MAKAWI AT, Tawfik YMK, Dixon DL, McMahon GM, et al
    Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease.
    Am J Nephrol. 2024 Feb 28:1-4. doi: 10.1159/000536540.
    PubMed    
    
    
    January 2024
66. HORI M, Takahashi H, Kondo C, Hayashi F, et al
    Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients Undergoing Chronic Haemodialysis.
    Am J Nephrol. 2024;55:399-405.
    PubMed     Abstract available
    
    
    
67. WANG Z, Zhou X, Shi S, Liu L, et al
    Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study.
    Am J Nephrol. 2024;55:529-538.
    PubMed     Abstract available
    
    
    
68. HOLDEN RM, Norman PA, Day AG, Silver SA, et al
    Vitamin D Status and Treatment in ESKD: Links to Improved CKD-MBD Laboratory Parameters in a Real-World Setting.
    Am J Nephrol. 2024;55:638-646.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.